JournalsHub
.online
Find My Journal
ST

Suzanne L. Topalian

Bloomberg (United States) US

ORCID 0000-0002-0821-8587
360
Publications
96,748
Citations
101
H-Index
212
i10-Index
10.5
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer OA
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer, Scott Gettinger, David C. Smith +25 more
New England Journal of Medicine 2012
12,546
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer OA
Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow, Wen-Jen Hwu, Suzanne L. Topalian +21 more
New England Journal of Medicine 2012
7,950
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy OA
Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll
Cancer Cell 2015
4,171
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates OA
Julie R. Brahmer, Charles G. Drake, Ira Wollner, John D. Powderly, Joel Picus +15 more
Journal of Clinical Oncology 2010
2,914
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes OA
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu +14 more
Science 2002
2,801

Publications

357 total

Neoadjuvant checkpoint blockade for cancer immunotherapy PDF

Suzanne L. Topalian, Janis M. Taube, Drew M. Pardoll - Science, 2020
Cited by 936 OpenAlex

Safety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melanoma

Jeffrey S. Weber, F. Stephen Hodi, Jedd D. Wolchok, Suzanne L. Topalian, Dirk Schadendorf et al. - Journal of Clinical Oncology, 2017
Cited by 1,145 OpenAlex

PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma PDF

Paul Nghiem, Shailender Bhatia, Evan J. Lipson, Ragini R. Kudchadkar, Natalie Miller et al. - New England Journal of Medicine, 2016
Cited by 1,235 OpenAlex

Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer PDF

Scott Gettinger, Leora Horn, Leena Gandhi, David R. Spigel, Scott Antonia et al. - Journal of Clinical Oncology, 2015
Cited by 1,189 OpenAlex

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll - Current Opinion in Immunology, 2012
Cited by 1,338 OpenAlex

Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 PDF

Eric V. Dang, Joseph Barbi, Huang‐Yu Yang, Dilini Jinasena, Hong Yu et al. - Cell, 2011
Cited by 1,551 OpenAlex

Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma PDF

Richard E. Royal, Catherine Lévy, Keli Turner, Aarti Mathur, Marybeth S. Hughes et al. - Journal of Immunotherapy, 2010
Cited by 1,224 OpenAlex

Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4 PDF

Kimberly E Beck, Joseph Blansfield, Khoi Q. Tran, Andrew L. Feldman, Marybeth S. Hughes et al. - Journal of Clinical Oncology, 2006
Cited by 832 OpenAlex

Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4 PDF

Peter Attia, Giao Q. Phan, Ajay V. Maker, Michael R. Robinson, Martha Quezado et al. - Journal of Clinical Oncology, 2005
Cited by 1,009 OpenAlex

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma PDF

Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian et al. - Proceedings of the National Academy of Sciences, 2003
Cited by 1,570 OpenAlex

Research Topics

Cancer Immunotherapy and Biomarkers (205) Immunotherapy and Immune Responses (152) CAR-T cell therapy research (86) Immune Cell Function and Interaction (64) T-cell and B-cell Immunology (38)

Frequent Co-Authors

ST
Steven A. Rosenberg
8 joint publications
JA
James Chih‐Hsin Yang
5 joint publications
RI
Richard M. Sherry
5 joint publications
DR
Drew M. Pardoll
5 joint publications
DO
Douglas J. Schwartzentruber
3 joint publications
CL
Claudia A. Seipp
3 joint publications

Affiliations

National Institutes of Health
US 2007 - 1987
Bloomberg (United States)
US 2025 - 2016
American Society of Clinical Oncology
US 2006 - 2006
The University of Texas MD Anderson Cancer Center
US 2010 - 2010
Howard Hughes Medical Institute
US 2003 - 2003

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now